Health Canada inspection
Biolyse Pharma Corporation: Health Canada inspection of Nov 22, 2024
Health Canada · GMP · rating C
Key facts
| Establishment | Biolyse Pharma Corporation |
|---|---|
| City | St. Catharines |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Nov 12, 2024 |
| End date | Nov 22, 2024 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101046 |
At a glance
- 10–99 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.